Autobio Diagnostics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	614.46	465.37	1,486	1,138	769.4	327.55
Short-Term Investments	-	3,574	2,333	3,141	3,000	3,092
Trading Asset Securities	268.45	3.61	700.57	-	7.34	85.89
Cash & Short-Term Investments	882.91	4,043	4,521	4,278	3,777	3,505
Cash Growth	6.10%	-10.57%	5.66%	13.27%	7.75%	303.80%
Accounts Receivable	1,188	1,177	1,181	1,074	1,003	958.87
Other Receivables	28.71	110.74	24.25	34.86	31.69	45.27
Receivables	1,216	1,288	1,206	1,109	1,035	1,004
Inventory	1,024	1,153	778.29	752.3	589.34	475.52
Other Current Assets	2,757	59.25	108.54	113.63	156.62	109.75
Total Current Assets	5,880	6,543	6,613	6,254	5,558	5,095
Property, Plant & Equipment	3,944	3,982	3,883	3,293	2,864	2,276
Long-Term Investments	178.68	172.54	123.31	13.76	1.72	83.42
Goodwill	164.65	164.65	164.65	164.65	164.65	164.65
Other Intangible Assets	139.35	136.09	179.03	203.27	227.85	252.2
Long-Term Deferred Tax Assets	363.4	335.66	274.61	238.73	201.76	157.83
Long-Term Deferred Charges	198.75	382.71	179.23	169.97	137.11	104.66
Other Long-Term Assets	858.05	158.7	137.55	135.59	78.07	3.21
Total Assets	11,727	11,875	11,554	10,472	9,233	8,137
Accounts Payable	1,352	1,135	726.15	1,010	355.24	438.73
Accrued Expenses	144.71	349.51	364.54	335.93	238.07	161.57
Short-Term Debt	39.53	240.21	353.28	113.84	121.39	206.63
Current Portion of Long-Term Debt	11.69	285	342	-	100.08	-
Current Portion of Leases	-	8.34	10.93	12.56	9.78	-
Current Income Taxes Payable	139.45	102.38	137.85	86.48	77.62	28.95
Current Unearned Revenue	84.38	166.11	148.14	135.48	125.1	95.86
Other Current Liabilities	509.14	372.71	400.25	472.27	431.28	325.19
Total Current Liabilities	2,281	2,660	2,483	2,167	1,459	1,257
Long-Term Leases	18.07	20.63	24.64	16.26	26.16	-
Long-Term Unearned Revenue	64	214.65	118.98	101.77	75.68	58.29
Long-Term Deferred Tax Liabilities	255.47	284.19	258.03	273.03	269.1	236.61
Other Long-Term Liabilities	263.21	4.25	2.92	2.22	-	-
Total Liabilities	2,881	3,183	2,888	2,560	1,829	1,552
Common Stock	571.42	581.01	586.27	586.27	586.27	450.98
Additional Paid-In Capital	3,358	3,819	4,101	4,101	4,101	4,250
Retained Earnings	4,816	4,676	4,091	3,338	2,590	1,771
Treasury Stock	-	-461.03	-243.3	-243.3	-	-
Comprehensive Income & Other	1.05	1.14	1.03	0.61	-0.07	5.25
Total Common Equity	8,747	8,617	8,535	7,783	7,277	6,477
Minority Interest	99.04	75.27	130.87	129.59	126.49	107.95
Shareholders' Equity	8,846	8,692	8,666	7,912	7,403	6,585
Total Liabilities & Equity	11,727	11,875	11,554	10,472	9,233	8,137
Total Debt	69.29	554.19	730.85	142.66	257.4	206.63
Net Cash (Debt)	813.63	3,488	3,790	4,136	3,520	3,299
Net Cash Growth	222.38%	-7.95%	-8.37%	17.50%	6.70%	20626.03%
Net Cash Per Share	1.42	6.05	6.54	7.08	6.00	5.91
Filing Date Shares Outstanding	571.42	576.91	581.01	581.01	586.27	586.27
Total Common Shares Outstanding	571.42	576.91	581.01	581.01	586.27	586.27
Working Capital	3,600	3,883	4,130	4,087	4,099	3,838
Book Value Per Share	15.31	14.94	14.69	13.39	12.41	11.05
Tangible Book Value	8,443	8,316	8,192	7,415	6,884	6,061
Tangible Book Value Per Share	14.77	14.41	14.10	12.76	11.74	10.34
Buildings	-	1,895	1,152	829.25	473.02	472.47
Machinery	-	2,916	2,740	2,492	2,283	1,892
Construction In Progress	-	987.28	1,591	1,272	1,105	641.8

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.